Ching Ching Leow

2.6k total citations
33 papers, 1.7k citations indexed

About

Ching Ching Leow is a scholar working on Molecular Biology, Oncology and Genetics. According to data from OpenAlex, Ching Ching Leow has authored 33 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Molecular Biology, 12 papers in Oncology and 6 papers in Genetics. Recurrent topics in Ching Ching Leow's work include Chronic Lymphocytic Leukemia Research (6 papers), Angiogenesis and VEGF in Cancer (6 papers) and Cancer Immunotherapy and Biomarkers (5 papers). Ching Ching Leow is often cited by papers focused on Chronic Lymphocytic Leukemia Research (6 papers), Angiogenesis and VEGF in Cancer (6 papers) and Cancer Immunotherapy and Biomarkers (5 papers). Ching Ching Leow collaborates with scholars based in United States, Italy and Poland. Ching Ching Leow's co-authors include Wei‐Qiang Gao, Sean E. Egan, Benoit St‐Pierre, Nicholas M. Durham, Ioanna Keklikoglou, Robert E. Hollingsworth, Ece Kadioglu, Michele De Palma, Nicolò Rigamonti and Paul Polakis and has published in prestigious journals such as Journal of Biological Chemistry, Nature Genetics and Journal of Clinical Oncology.

In The Last Decade

Ching Ching Leow

33 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ching Ching Leow United States	18	887	723	501	197	176	33	1.7k
Diana Klein Germany	32	1.3k 1.4×	407 0.6×	245 0.5×	406 2.1×	332 1.9×	74	2.3k
Rossano Cesari United States	20	1.1k 1.3×	664 0.9×	443 0.9×	268 1.4×	190 1.1×	34	2.1k
Lawrence E. Goldfinger United States	22	1.1k 1.2×	359 0.5×	277 0.6×	388 2.0×	98 0.6×	55	2.2k
Ashreena Salpekar United Kingdom	8	1.1k 1.3×	286 0.4×	527 1.1×	172 0.9×	112 0.6×	8	1.7k
Kenji Yumoto United States	22	579 0.7×	550 0.8×	237 0.5×	232 1.2×	247 1.4×	35	1.6k
Jack F. Shern United States	23	1.5k 1.7×	2.1k 2.9×	733 1.5×	256 1.3×	431 2.4×	53	3.4k
Nathalie Gallay France	18	825 0.9×	313 0.4×	221 0.4×	176 0.9×	92 0.5×	33	1.8k
Eleni Maniati United Kingdom	19	580 0.7×	750 1.0×	708 1.4×	272 1.4×	155 0.9×	40	1.6k
Mark Winderlich Germany	12	896 1.0×	354 0.5×	352 0.7×	185 0.9×	110 0.6×	25	1.6k
Kim De Veirman Belgium	26	1.3k 1.5×	699 1.0×	564 1.1×	514 2.6×	65 0.4×	69	2.1k

Countries citing papers authored by Ching Ching Leow

Since Specialization

Citations

This map shows the geographic impact of Ching Ching Leow's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ching Ching Leow with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ching Ching Leow more than expected).

Fields of papers citing papers by Ching Ching Leow

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ching Ching Leow. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ching Ching Leow. The network helps show where Ching Ching Leow may publish in the future.

Co-authorship network of co-authors of Ching Ching Leow

This figure shows the co-authorship network connecting the top 25 collaborators of Ching Ching Leow. A scholar is included among the top collaborators of Ching Ching Leow based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ching Ching Leow. Ching Ching Leow is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Harding, James J., Víctor Moreno, Yung‐Jue Bang, et al.. (2021). Blocking TIM-3 in Treatment-refractory Advanced Solid Tumors: A Phase Ia/b Study of LY3321367 with or without an Anti-PD-L1 Antibody. Clinical Cancer Research. 27(8). 2168–2178. 116 indexed citations

Hellmann, Matthew D., Nicoletta Bivi, Boris Calderón, et al.. (2021). Safety and Immunogenicity of LY3415244, a Bispecific Antibody Against TIM-3 and PD-L1, in Patients With Advanced Solid Tumors. Clinical Cancer Research. 27(10). 2773–2781. 84 indexed citations

Jurczak, Wojciech, Caroline Dartigeas, Marta Coscia, et al.. (2021). BRUIN CLL-313: A Phase 3 Open-Label, Randomized Study of Pirtobrutinib Versus Bendamustine Plus Rituximab in Untreated Patients with Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (Trial in Progress). Blood. 138(Supplement 1). 3732–3732. 2 indexed citations

Novick, Steven, Kris F. Sachsenmeier, Ching Ching Leow, Lorin Roskos, & Harry Yang. (2018). A Novel Bayesian Method for Efficacy Assessment in Animal Oncology Studies. Statistics in Biopharmaceutical Research. 10(3). 151–157. 3 indexed citations

Durham, Nicholas M., et al.. (2017). GITR ligand fusion protein agonist enhances the tumor antigen–specific CD8 T-cell response and leads to long-lasting memory. Journal for ImmunoTherapy of Cancer. 5(1). 47–47. 31 indexed citations

Rios‐Doria, Jonathan, Nicholas M. Durham, Leslie Wetzel, et al.. (2015). Doxil Synergizes with Cancer Immunotherapies to Enhance Antitumor Responses in Syngeneic Mouse Models. Neoplasia. 17(8). 661–670. 146 indexed citations

Huang, Qihui, Nicholas M. Durham, Erin Sult, et al.. (2015). Abstract 1538: Levels and enzyme activity of CD73 in primary samples from cancer patients. Cancer Research. 75(15_Supplement). 1538–1538. 9 indexed citations

Rigamonti, Nicolò, et al.. (2014). Role of Angiopoietin-2 in Adaptive Tumor Resistance to VEGF Signaling Blockade. Cell Reports. 8(3). 696–706. 180 indexed citations

Syrjälä, S., Raimo Tuuminen, Antti I. Nykänen, et al.. (2014). Angiopoietin-2 Inhibition Prevents Transplant Ischemia-Reperfusion Injury and Chronic Rejection in Rat Cardiac Allografts. American Journal of Transplantation. 14(5). 1096–1108. 31 indexed citations

10.

Zheng, Wei, Harri Nurmi, Sila Appak‐Baskoy, et al.. (2014). Angiopoietin 2 regulates the transformation and integrity of lymphatic endothelial cell junctions. Genes & Development. 28(14). 1592–1603. 97 indexed citations

11.

Wang, Lin, Hui Feng, Kristen Lekstrom, et al.. (2013). Multivalent Scaffold Proteins as Superagonists of TRAIL Receptor 2–Induced Apoptosis. Molecular Cancer Therapeutics. 12(7). 1235–1244. 43 indexed citations

12.

Holopainen, Tanja, Pipsa Saharinen, Gabriela D’Amico, et al.. (2012). Effects of Angiopoietin-2-Blocking Antibody on Endothelial Cell–Cell Junctions and Lung Metastasis. JNCI Journal of the National Cancer Institute. 104(6). 461–475. 6 indexed citations

13.

Leow, Ching Ching, Bu-Er Wang, Jed Ross, et al.. (2009). Prostate-specific Klf6 Inactivation Impairs Anterior Prostate Branching Morphogenesis through Increased Activation of the Shh Pathway. Journal of Biological Chemistry. 284(31). 21057–21065. 19 indexed citations

14.

Gum, James R., Suzanne Crawley, Sanjay Kakar, et al.. (2006). HATH1 Expression in Mucinous Cancers of the Colorectum and Related Lesions. Clinical Cancer Research. 12(18). 5403–5410. 54 indexed citations

15.

Leow, Ching Ching, Paul Polakis, & Wei‐Qiang Gao. (2005). A Role for Hath1, a bHLH Transcription Factor, in Colon Adenocarcinoma. Annals of the New York Academy of Sciences. 1059(1). 174–183. 23 indexed citations

16.

Leow, Ching Ching, Xi-De Wang, & Wei‐Qiang Gao. (2005). Novel method of generating prostate-specificCre-LoxP gene switching via intraductal delivery of adenovirus. The Prostate. 65(1). 1–9. 12 indexed citations

17.

Wang, Xi-De, Ching Ching Leow, Jiping Zha, et al.. (2005). Notch signaling is required for normal prostatic epithelial cell proliferation and differentiation. Developmental Biology. 290(1). 66–80. 121 indexed citations

18.

Leow, Ching Ching, Maria S. Romero, Sarajane Ross, Paul Polakis, & Wei‐Qiang Gao. (2004). Hath1, Down-Regulated in Colon Adenocarcinomas, Inhibits Proliferation and Tumorigenesis of Colon Cancer Cells. Cancer Research. 64(17). 6050–6057. 107 indexed citations

19.

Egan, Sean E., Benoit St‐Pierre, & Ching Ching Leow. (1998). Notch Receptors, Partners and Regulators: From Conserved Domains to Powerful Functions. Current topics in microbiology and immunology. 228. 273–324. 105 indexed citations

20.

Cohen, Brenda, Arash Bashirullah, Lina Dagnino, et al.. (1997). Fringe boundaries coincide with Notch-dependent patterning centres in mammals and alter Notch-dependent development in Drosophila. Nature Genetics. 16(3). 283–288. 131 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact